logo

Indian News

Share

pharmadown-dec13.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharmaup-dec13.jpg The following are some of today's top gainers in the pharma/biotech sector.

bankruptcyworriedhappy-dec13.jpg Today's Daily Dose brings you news about disappointing trial results of Applied Genetic Technologies; near-term catalyst of Idera; stock offering of Marinus; disappointing Tourette syndrome trial results of Neurocrine Biosciences; bankruptcy proceedings of Synergy Pharma; Complete Response Letter for Mallinckrodt's pain drug, and promising data from Zynerba's phase II Fragile X Syndrome trial.

pharmaup-dec12.jpg The following are some of today's top gainers in the pharma/biotech sector.

redheads-dec12.jpg Studies involving redheads, who make up about 2% of the global population, have always been of great interest. That redheads are more sensitive to pain, require 20 percent more anesthesia than others, and are more likely to be left-handed are some of the fascinating facts about them.

pharmadown-dec11.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharmaup-dec11.jpg The following are some of today's top gainers in the pharma/biotech sector.

shaktikanta-rbi-121118.jpg India's government named veteran bureaucrat Shaktikanta Das as the new governor of the Reserve Bank of India, following the abrupt resignation of Urjit Patel on Monday. Das, a former economic affairs secretary, has been appointed for a period of three years, the government said in a statement. A retired officer of the Indian Administrative Service, Das will be the 25th governor of the RBI.

pharma-dec11.jpg Today's Daily Dose brings you news about Axovant's disappointing phase II trial in REM sleep behavior disorder; progress in Axsome Therapeutics' ADVANCE-1 study of Alzheimer's; Menlo Therapeutics' promising results from phase II trial of Serlopitant in pruritus associated with psoriasis, and Ra Pharma's generalized myasthenia gravis study results.

Follow RTT